The present invention generally relates to a patient support, and more particularly to a patient mattress for a hospital bed.
The present invention provides a mattress for supporting a patient with one or more cushioning layers that provide immersion and pressure distribution to a patient supported on the mattress.
In one form of the invention, a patient support includes a plurality of cushioning layers arranged such that their supporting surfaces when unloaded are generally arranged in a plane. Each cushioning layer is interlocked with each adjacent cushioning layer wherein each cushioning layer provides lateral and longitudinal support to each of its adjacent cushion layers.
In one aspect, the cushioning layers include a bladder layer.
In another aspect, the cushioning layers include a gel layer.
According to yet another aspect, at least one of the cushioning layers includes transverse openings allowing air to pass through the at least one cushioning layer to direct air flow through the at least one cushioning layer.
In any of the above supports, the patient support may include a plurality of inflatable bladders and a gel layer adjacent the inflatable bladders. For example, the gel layer may interlock with adjacent bladders of the inflatable bladders.
In another aspect, each of the bladders has a hexagonal cross-section. In addition or alternately, the gel layer may include a plurality of hexagonal gel footings. For example, each of the gel footings may be disconnected from its adjacent gel footings. Optionally, each of the gel footings may be internally reinforced by a plurality of hexagonal gel wall structures.
According to yet another aspect, the cushioning layers are supported on a foam crib.
In addition, the support optionally includes turning bladders positioned below the foam crib, with the foam crib including at least two hinged panels to allow turning of a patient supported on the patient support.
In another aspect, the support includes a cover and is configured to flow air through the support beneath the cover to manage moisture that may build up under the cover, which is formed from a material that prevents liquid intrusion but allows gas and moisture to flow through the cover.
For example, the foam crib may include a plurality of channels extending there through for directing air through the foam crib and into at least one of the cushioning layers. Additionally, the foam crib may support or house one or more blowers to direct air though the channels.
In another aspect, the support cover includes a mesh panel that permits air to be drawn into the cover by the blower units.
Accordingly, the present invention provides a support surface that provides a patient with pressure distribution and optionally improved moisture management.
Before the embodiments of the invention are explained in more detail below, it is to be understood that the invention is not limited to the details of operation or to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention may be implemented in various other embodiments and is capable of being practiced or being carried out in alternative ways not expressly disclosed herein. Also, it is to be understood that the phraseology and terminology used herein are for the purpose of description and should not be regarded as limiting. The use of “including” and “comprising” and variations thereof is meant to encompass the items listed thereafter and equivalents thereof as well as additional items and equivalents thereof. Further, enumeration may be used in the description of various embodiments. Unless otherwise expressly stated, the use of enumeration should not be construed as limiting the invention to any specific order or number of components. Nor should the use of enumeration be construed as excluding from the scope of the invention any additional steps or components that might be combined with or into the enumerated steps or components.
Referring to
Referring again to
For example, patient support apparatus 12 may include one or more controls that are integrated therein and which are used in controlling one or more functions of patient support 10, as will be discussed in greater detail below. For example, electrical connectors may be provided for establishing an electrical link between a user interface that is positioned on, or integrated into, the barrier of patient support apparatus 12. The user interface may take on a variety of different forms, such as, but not limited to, a touch screen, a Liquid Crystal Display (LCD), a plurality of buttons, switches, knobs, or the like, or any combination of these components, which allows a user to control the operation of patient support 10. The connection between the interface and patient support 10 may take on different forms, including a direct electrical cable that runs from the footboard to patient support 10, for example by way of electrical connectors that electrically couple the user interface to circuitry supported on or in the frame of the bed, and/or by wireless communication, such as disclosed in commonly assigned, U.S. patent application Ser. No. 13/802,855, filed Mar. 14, 2013, by applicants Michael Hayes et al. and entitled COMMUNICATION SYSTEMS FOR PATIENT SUPPORT APPARATUSES, the complete disclosure of which is hereby incorporated herein by reference. For more exemplary details of a suitable hospital bed reference is made to the beds described in U.S. Pat. Nos. 8,006,332; 7,690,059; 7,805,784; 7,962,981; and 7,861,334, all commonly owned by Stryker Corporation of Kalamazoo, Mich., which are herein incorporated by reference in their entireties.
Referring to
In another aspect, cover 14 may include one or more indicia on its surface. For example, cover 14 may include indicia to define the preferred location for a patient on patient support 10. The indicia may include a demarcation 16, such as a line, that defines the overall general area in which the patient should be positioned in the supine position and additional demarcations 18, 20, 22, and 24, also for example lines, that define the foot area, the thigh and seat areas, the back areas, and the head area of the patient support. In this manner, when a patient is located in the general area and also generally aligned with the sub-areas, the patient will be properly aligned with the support cushioning layers and turning bladders that are configured to provide the appropriate cushioning and functionality to that region of the patient's body.
In addition to the demarcation lines that identify the different areas/sections of the support, other indicia may be applied for example, graphical instructions, representations of the underlying cushioning layers (e.g. the gel or bladders), as well as the location of optional percussion/vibration and/or turning bladders to again facilitate the proper positioning of the patient.
The various demarcations, which for example indicate the different areas of support, i.e. thigh and back support areas, foot support areas, and head support areas, may be applied to the underlying sheet that forms the cover using a heat transfer process. For example, ink that is applied to a carrier sheet may be transferred onto the fabric that forms the cover using heat. In this manner, the ink does not simply coat the fabric, as is the case with silk screening, and instead merges with the fabric (and optionally underlying elastomeric membrane) which provides the sheet with generally constant properties. This tends to reduce the wear and provide increased longevity to the demarcations.
To provide appropriate cushioning and immersion for the patient, patient support 10 includes a bladder layer 26 with a plurality of bladders 26a, 26b, which provide support to the patient's thighs, seat, back, and head, and a gel layer 28, which provides support to the patient's heels. Bladder layer 26 may be formed from a sheet of gelatinous elastomeric material, which is configured, such as by molding, including injection molding, blow molding, thermoforming, or cast molding, to include a plurality of sacs or cavities, which form upper wall 26c and side walls 26d of each bladder 26a, 26b, which is then joined with a bottom sheet 26e to form the closed chambers of the bladders (see
Referring to
In the illustrated embodiment, bladders 26a, 26b are arranged in zones, which optionally may be independently controlled with the inflation/deflation of each zone independent of the other zone or zones. For example, the zones may include a head zone at the head end 10a of support 10, a back zone at the back section 10c of support 10, seat and thigh zones at the seat and thigh sections 10d, and a heel zone at the foot end 10b of patient support 10. Further, each zone may be divided, for example into a left sub-zone and a right sub-zone so that when a patient is being turned, the pressure on the bladders on one side may be adjusted (e.g. increased or decreased) to accommodate the motion of the patient. For example, in the illustrated embodiment, the seat zone includes a right seat zone and a left seat zone to facilitate turning the patient. In the illustrated embodiment, the back zone and the head zone are grouped together and, further, positioned so that they will generally be aligned together when the patient is positioned on support 10
Referring to
Referring again to
Gel layer 28 is formed from a gelastic material. Suitable gelastic materials include a SEB, SEBS, SEP, SEPS, SEEP, SEEPS polymer combined with a mineral oil, such as disclosed in U.S. Pat. Nos. 3,485,787; 3,676,387; 3,827,999; 4,259,540; 4,351,913; 4,369,284; 4,618,213; 5,262,468; 5,508,334; 5,239,723; 5,475,890; 5,334,646; 5,336,708; 4,432,607; 4,492,428; 4,497,538; 4,509,821; 4,709,982; 4,716,183; 4,798,853; 4,942,270; 5,149,736; 5,331,036; 5,881,409; 5,994,450; 5,749,111; 6,026,527; 6,197,099; 6,865,759; 7,060,213; 6,413,458; 7,730,566; and 7,964,664, which are all incorporated herein by reference in their entireties.
As one example, the gelatinous elastomeric material may be formulated with a weight ratio of oil to polymer of approximately 3.1 to 1. The polymer may be Kraton 1830 available from Kraton Polymers, which has a place of business in Houston, Tex., or it may be another suitable polymer. The oil may be mineral oil, or another suitable oil. One or more stabilizers may also be added. Additional ingredients—such as, but not limited to—dye may also be added. In another example, the gelatinous elastomeric material may be formulated with a weight ratio of oil to copolymers of approximately 2.6 to 1. The copolymers may be Septon 4055 and 4044 which are available from Kuraray America, Inc., which has a place of business in Houston, Tex., or it may be other copolymers. If Septon 4055 and 4044 are used, the weight ratio may be approximately 2.3 to 1 of Septon 4055 to Septon 4044. The oil may be mineral oil and one or more stabilizers may also be used. Additional ingredients—such as, but not limited to—dye may also be added. In addition to these two examples, as well as those disclosed in the aforementioned patents, still other formulations may be used.
In the illustrated embodiment, gel layer 28 includes a plurality of gelastic footings 29 that are disconnected from each other so that each footing can compress independently from its adjacent surrounding footing. The term footing is used in the sense that the overall gel structure (defined by outer perimeter wall 30) is wider than it is tall. Referring to
For example, the height of each wall may be in a range of about 1″ to 4″, or in a range of about 2″ to 3″, and the thickness of each wall may be in a range of about 1/32″ to ⅜″ or in a range of about 1/16″ to/¼″. The width of each footing may be in a range of about 3″ to 6″ or in a range of about 4″ to 5″, with each internal hexagonal-shaped wall in a range of about 1″ to 2″ or in a range of about ¾ to 1½″. To facilitate injection molding, the walls are slightly tapered, for example, to create a draft angle. For example, the draft angle may fall in a range of about 1 degrees to 10 degrees or in a range of about 3 degrees to 8 degrees
In this manner, each gel footing 30 provides a nested set of interconnected gel walls that tend to buckle under the weight of a patient and continue to provide cushioning support to the patient's heels over the full range of collapse of each group of the internal walls. By spreading the load across multiple walls that are interconnected but arranged in isolated groups, each grouping will allow greater immersion and provide better redistribution of stress or pressure across the patient's heel then when all the walls are tied together.
In addition, each gel wall of each gel footing may be joined at their lowermost edges by a base sheet of gel, which is relatively thin, like a skin, which is used in the molding process to help distribute the gel material across the full width of the gel layer.
Further, the gel forming gel layer 28 may be selected to very soft, but with the interconnection of the adjacent inner walls still provide adequate support and cushioning to the patient's heel. For examples of other gel configurations that may be used, including gel columns (where the gel structures have a greater height than their width), reference is again made to U.S. Pat. Nos. 3,485,787; 3,676,387; 3,827,999; 4,259,540; 4,351,913; 4,369,284; 4,618,213; 5,262,468; 5,508,334; 5,239,723; 5,475,890; 5,334,646; 5,336,708; 4,432,607; 4,492,428; 4,497,538; 4,509,821; 4,709,982; 4,716,183; 4,798,853; 4,942,270; 5,149, 736; 5,331,036; 5,881,409; 5,994,450; 5,749,111; 6,026,527; 6,197,099; 6,843,873; 6,865,759; 7,060,213; 6,413,458; 7,730,566; 7,823,233; 7,827,636; 7,823,234; and 7,964,664, which are all incorporated herein by reference in their entireties.
As best seen in
Foam crib portion 40a includes a base wall 42 and a pair of upwardly extending sidewalls 44, which as noted form a foam rail along opposed sides of bladder layer 26 to facilitate entry to and exit from the bed, and to cradle the patient when they are in the supine position. Referring to
Blower units 50, when operated, blow air into channels 46a and 46, which in turn distribute the air into branch channels 48 to generate air flow into the bladder layer 26 from beneath. To allow the air to flow through bladder layer 26, the base sheet 26e of bladder layer 26 includes a plurality of openings 26g (
Referring again to
Inwardly facing sides of sidewalls 44 optionally include a plurality of recesses 62 that at least generally follow the contour of each adjacent bladder 26a to thereby provide lateral support to each adjacent bladder both in the lateral and longitudinal direction. As a result, bladders 26a are held in place and, to a certain extent, somewhat interlocked with each other given their own interlocking arrangement. Similarly, as seen in
As best seen in
Further, foam base wall 66 of foam crib section 40b includes a plurality of recesses to receive the lower ends of each bladder at the foot end of bladder layer 26 and, further, provide downwardly tapered upper surfaces adjacent each recess so that the gel footings at the thigh end of gel layer 28 are sloped downwardly to provide a smooth transition between the adjacent gel layer and bladder layer. This transition is optionally aligned generally between the knee and thigh of the patient supported on patient support 10.
As best seen in
To deliver air to bladders 26a and 26b and to turning bladders 70a and 70b, support 10 includes a pneumatic system. In this illustrated embodiment, the pneumatic system includes a pneumatic harness 80, which includes a plurality of tubing sections 84 that are supported and secured to a fabric carrier that secures the various tubing sections and associated connectors 86 in their desired configuration and locations. In this manner, when harness 80 is placed over crib 40, the tubing and its associated connectors can be easily aligned with the appropriate inlets for inflating the respective bladders. Together, the tubing and fabric carrier form a flexible manifold that can be easily located in a position with an inlet end (where the tubing exits the carrier) positioned and aligned for coupling to the pump or pumps that supply the air to the respective bladders. The pump or pumps that supply air to the tubing are optionally located in a box at the foot end of the support, more fully described below.
As noted above, the various tubing that supplies the bladders with air are coupled to a pump or pumps, which in the illustrated embodiment are located in a pump box 90 shown in
As noted above, bladders 26a, 26b are inflated, or deflated, in groups or zones as described above under the control of box 90 and its associated pumps and control circuitry. The fluid connections between the bladders and box 90 are established by the tubing 84 that run between box 90 and the various bladders and which connect to inlets on the bladders by connectors 86. As noted above, tubing 84 is attached to housed in a fabric carrier which together form the flexible manifold 80.
Similarly, manifold 80 may support the tubing for turning bladders 70a, 70b, which extend generally longitudinally in a direction from the head end 10a to foot end 10b, and as noted are positioned underneath foam crib 40 and are used to help turn a patient positioned on top of patient support 10. To that end, turn bladders and are each separately and independently inflatable and deflatable, which is also controlled by box 90 and its associated circuitry.
For example, as discussed in reference to copending application U.S. Ser. No. 61/696,819, filed Sep. 5, 2012, entitled INFLATABLE MATTRESS AND CONTROL METHODS, patient support 10 may incorporate sensors, such as depth sensor plates 92, for sensing the immersion of a patient into the surface. Based on the sensed immersion, the controller, which also may be located in box 90 or elsewhere, including for example in recesses 94 formed in foam crib 40 (
Fabric 102 is positioned on top of bladder layer 26 but over a fire sock or barrier 100, which wraps around bladder layer 26 and is made of any suitable material that resists the spread of fire. Such materials may vary. In one embodiment, fire barrier 100 may be made of, or include, Kevlar® (poly-paraphenylene terephthalamide), or other brands of para-aramid synthetic fibers. Other materials may alternatively be used. Cover 14, which includes an upper cover portion 14a and a lower cover portion 14b, therefore encloses fabric 102, sock 100, bladder layer 26, gel layer 28, crib 40, turning bladders 70a, 70b, and plates 92, as well as pump box 90 and the pneumatic manifold. For example, upper cover portion 14a and a lower cover portion 14b may be secured together by a zipper, which allows access to the various components inside support 10.
As noted above, when one of the turning bladders is inflated, the corresponding hinged panel of foam crib will raise up. At the same time, the air in the bladders above the rising panel may either be maintained or increased, while the pressure on the bladders on the opposite side may be reduced or even deflated.
In addition to turning a patient, sections of patient support 10 may be folded to accommodate the Fowler being raised or the leg section of being lowered. For example, support 10 may be supported on a bed with an articulating deck, with a head section, a back section, a seat section and a leg section, with one or more sections being pivotable to raise the Fowler or leg sections as noted. To accommodate the articulating deck, foam crib may include a corresponding gatch for each point of articulation (see
When assembled, therefore, patient support 10 not only includes a cushioning layer that provides a pressure redistribution system to enhance the support of a patient lying upon support 10 but also optionally provides a moisture management system, as well as an immersion control system. As noted above, additional functionalities may be provided in a form of configuring some of the bladders as percussion and/or vibration bladders, such as described in the referenced copending applications It should be understood that patient support 10 may be modified to include one or more bladders in the foot zone in lieu of the gel layer and, therefore, the air pressure inside of these bladders could be monitored and controlled by the same system that controls the feet section bladders, thigh and seat section bladders, and head section bladders.
Accordingly, the present invention provides a patient support that provides a mattress with inflatable support bladders that offer improved immersion of the patient into the surface of the mattress and, therefore, improved pressure distribution to the patient. With the independent discrete bladder arrangement, it has been found that a more balance contact (see
While several forms of the invention have been shown and described, other changes and modifications will be appreciated by those skilled in the relevant art. Therefore, it will be understood that the embodiments shown in the drawings and described above are merely for illustrative purposes, and are not intended to limit the scope of the invention which is defined by the claims which follow as interpreted under the principles of patent law including the doctrine of equivalents.
This application claims the benefit of U.S. provisional application U.S. provisional application Ser. No. 61/697,010 (P405) filed Sep. 5, 2012, entitled PATIENT SUPPORT, which is incorporated by reference herein in its entirety. This application is related to U.S. provisional application Ser. No. 61/837,067 (P405A) filed Jun. 19, 2013, entitled PATIENT SUPPORT COVER Ser. No. 61/507,371, filed Jul. 13, 2011, entitled PATIENT/INVALID HANDLING SUPPORT; copending U.S. application Ser. No. 13/548,591, filed Jul. 13, 2012, entitled PATIENT/INVALID HANDLING SUPPORT; U.S. copending application Ser. No. 13/022,326, filed Feb. 7, 2011, entitled PATIENT/INVALID HANDLING SUPPORT; U.S. copending application Ser. No. 13/022,372, filed Feb. 7, 2011, entitled PATIENT/INVALID HANDLING SUPPORT; U.S. copending application Ser. No. 13/022,382, filed Feb. 7, 2011, entitled PATIENT/INVALID HANDLING SUPPORT; U.S. copending application Ser. No. 13/022,454, filed Feb. 7, 2011, entitled PATIENT/INVALID HANDLING SUPPORT; U.S. copending application Ser. No. 12/640,770, filed Dec. 17, 2009, entitled PATIENT SUPPORT; and U.S. copending application Ser. No. 12/640,643, filed Dec. 17, 2009, entitled PATIENT SUPPORT.
Number | Name | Date | Kind |
---|---|---|---|
3222697 | Scheermesser | Dec 1965 | A |
3319274 | Upton | May 1967 | A |
3742528 | Munch | Jul 1973 | A |
3846857 | Weinstock | Nov 1974 | A |
4536906 | Varndell et al. | Aug 1985 | A |
4719656 | Godinet | Jan 1988 | A |
4843664 | Farnworth et al. | Jul 1989 | A |
5027458 | Osczevski et al. | Jul 1991 | A |
5546618 | Beedy et al. | Aug 1996 | A |
5551107 | Graebe | Sep 1996 | A |
5561875 | Graebe | Oct 1996 | A |
5623736 | Soltani et al. | Apr 1997 | A |
5704084 | Evans et al. | Jan 1998 | A |
5953779 | Schwartz | Sep 1999 | A |
5966763 | Thomas et al. | Oct 1999 | A |
5991949 | Miller et al. | Nov 1999 | A |
6047424 | Osborne et al. | Apr 2000 | A |
6119291 | Osborne et al. | Sep 2000 | A |
6223369 | Maier et al. | May 2001 | B1 |
6401282 | Shum | Jun 2002 | B1 |
6519797 | Brubaker et al. | Feb 2003 | B1 |
6760937 | Ou | Jul 2004 | B1 |
8108957 | Richards et al. | Feb 2012 | B2 |
20020129449 | Harker | Sep 2002 | A1 |
20020148045 | Giori et al. | Oct 2002 | A1 |
20030030319 | Clapper | Feb 2003 | A1 |
20030135930 | Varese et al. | Jul 2003 | A1 |
20050273940 | Petrosenko et al. | Dec 2005 | A1 |
20060075559 | Skinner et al. | Apr 2006 | A1 |
20060112489 | Bobey et al. | Jun 2006 | A1 |
20060168736 | Meyer et al. | Aug 2006 | A1 |
20070000060 | Firestone | Jan 2007 | A1 |
20070101505 | Oprandi | May 2007 | A1 |
20070157394 | Giggleman | Jul 2007 | A1 |
20070277320 | Massmann | Dec 2007 | A1 |
20080028533 | Stacy et al. | Feb 2008 | A1 |
20080078033 | Wyatt et al. | Apr 2008 | A1 |
20080148481 | Brykalski et al. | Jun 2008 | A1 |
20080263763 | Butler | Oct 2008 | A1 |
20080282471 | Chambers et al. | Nov 2008 | A1 |
20090013470 | Richards et al. | Jan 2009 | A1 |
20090013472 | Koffler et al. | Jan 2009 | A1 |
20090183313 | Poulos | Jul 2009 | A1 |
20100063638 | Skinner | Mar 2010 | A1 |
20100175196 | Lafleche et al. | Jul 2010 | A1 |
20100281618 | O'Reagan | Nov 2010 | A1 |
20110010865 | Flick et al. | Jan 2011 | A1 |
20110113561 | Douglas | May 2011 | A1 |
20110209289 | Meyer et al. | Sep 2011 | A1 |
20110289691 | Lafleche et al. | Dec 2011 | A1 |
20110302720 | Yakam et al. | Dec 2011 | A1 |
20120186587 | Steffens et al. | Jul 2012 | A1 |
20130061396 | Lafleche et al. | Mar 2013 | A1 |
20130067662 | Jusiak et al. | Mar 2013 | A1 |
20130219626 | Clapper | Aug 2013 | A1 |
20140059781 | Lafleche et al. | Mar 2014 | A1 |
20140090178 | Morgan et al. | Apr 2014 | A1 |
20140237722 | Gibson et al. | Aug 2014 | A1 |
20140237726 | Gibson et al. | Aug 2014 | A1 |
20140373279 | Lafleche et al. | Dec 2014 | A1 |
20150013073 | Schwirian et al. | Jan 2015 | A1 |
20150059100 | Brubaker et al. | Mar 2015 | A1 |
20150082550 | Hui | Mar 2015 | A1 |
20150101126 | Reiners et al. | Apr 2015 | A1 |
Entry |
---|
PCT International Search Report for Application No. PCT/US2013/058235 filed on Sep. 5, 2013. |
PCT Written Opinion for Application No. PCT/US2013/058235 filed on Sep. 5, 2013. |
Number | Date | Country | |
---|---|---|---|
20140059780 A1 | Mar 2014 | US |
Number | Date | Country | |
---|---|---|---|
61697010 | Sep 2012 | US |